Retatrutide Shows Significant Weight Loss in Diabetes Phase III Trial | Retatrutide News

Retatrutide demonstrated significant weight loss in a Phase III trial for people with diabetes. This result highlights its potential in the treatment of...
Clinical Trials · October 15, 2026